Tox In Focus | Synthetic Cathinones

Tox In Focus

Focused Clinical Reference

Vol. 10 · Synthetic Cathinones · July 2026

Drug Quick Reference

Drug Class / Mechanism

Synthetic cathinone stimulants

CNS stimulants (cocaine / methamphetamine / MDMA-like)

Street Names

Bath Salts, Bliss, Cloud Nine

Ivory Wave, Meow Meow

Routes of Administration

Intranasal (most common), oral

Smoked or injected

Commonly Detected With

Other stimulants · Marketed as 'research chemicals'

Metabolism

Metabolism similar to MDMA (structural analog)

Significant fraction excreted unchanged

Window of Detection

Est. 2 to 3 days after acute use (MDMA-class data)

Long-term-use window not established

Control Status

Many synthetic cathinones: DEA Schedule I

Analogues marketed to evade scheduling

SYNTHETIC CATHINONES

'Bath salts' stimulants that standard amphetamine screens can miss

Synthetic cathinones are stimulants designed to mimic cocaine, methamphetamine, and MDMA. Sold as 'bath salts' or 'research chemicals' and labeled 'not for human consumption' to evade controls, they are not reliably detected by standard amphetamine screens and require targeted LC-MS/MS.¹

Why This Matters Now

Synthetic cathinones are marketed under evolving names and sold in convenience stores, smoke shops, and online, with new analogues introduced to circumvent the Controlled Substance Analogue Enforcement Act.¹ Many, including eutylone and methylone, are Schedule I and can cause severe agitation, psychosis, hyperthermia, and death.²

⚠ A negative amphetamine immunoassay does not exclude synthetic cathinone use. When stimulant toxicity is present but the amphetamine screen is negative, request targeted cathinone LC-MS/MS.

Clinical Presentation

INTOXICATION

Euphoria, increased energy, sociability

Agitation, paranoia, psychosis

Tachycardia, hypertension

Hyperthermia, diaphoresis

Rhabdomyolysis, seizures (severe)

WITHDRAWAL

Fatigue, hypersomnia

Depressed mood

Anxiety, irritability

Craving

Course not well characterized

Important: Severe synthetic cathinone toxicity can present with agitation, hyperthermia, and rhabdomyolysis; management is supportive. A negative amphetamine screen does not rule it out.

UDT Considerations

Synthetic cathinones are not reliably detected by amphetamine immunoassays and require targeted LC-MS/MS. Panels measure specific analytes such as eutylone and methylone; a 'bath salts' product may contain other cathinones not on the panel, which would read negative. Metabolism resembles that of MDMA, with a significant fraction excreted unchanged.³

Clinical Guidance

Do not rely on amphetamine immunoassays to detect synthetic cathinones; order targeted LC-MS/MS.
Interpret a negative cautiously: the product may contain a cathinone not included on the panel.
Correlate results with the clinical picture; stimulant toxicity can precede or exceed what testing captures.
Recognize that product names and formulations change frequently, so panel coverage may lag the market.
Screen for co-use of other stimulants and depressants.

Point-of-Care Testing Availability

Available strips

No point-of-care strip detects synthetic cathinones.

Clinical use

Standard amphetamine immunoassays do not reliably detect most synthetic cathinones.

Limitations

Confirmation requires targeted LC-MS/MS for specific analytes (e.g., eutylone, methylone).

SYNTHETIC CATHINONES | Clinical & Program Guidance

Tox In Focus Vol. 10 · July 2026 · Page 2 of 2

Interpreting the Test Result

▲ If Testing Is Positive

Confirms a specific cathinone. Detection of eutylone or methylone indicates recent use within the window of detection.

Timing is uncertain. Detection may extend roughly 2 to 3 days after acute use; use caution estimating time of last use.⁴

Quantity does not equal dose. Levels are reported in ng/mL and do not establish amount taken.

▼ If Testing Is Negative or Not Done

Does not exclude 'bath salts' use. A product may contain a cathinone not measured by the panel, producing a negative.

Not covered by amphetamine screens. Standard amphetamine immunoassays do not reliably detect these agents.

Timing and cutoff. Absence may reflect timing of last use, dose, or levels below the cutoff.

Metabolism & Urinary Markers

Representative synthetic cathinones on the definitive panel; the class is broad and evolving.

Metabolite	Clinical Significance
Eutylone	Schedule I synthetic cathinone; a common current 'bath salts' constituent.
Methylone	Schedule I cathinone (MDMA-like); measured directly on the panel.
Other cathinones	Many analogues exist; those outside the panel will not be detected.

Key References

US Drug Enforcement Administration. Drugs of Abuse: A DEA Resource Guide, 2020 Edition. 2020.
US Drug Enforcement Administration. Methylone and Eutylone drug fact sheets. 2019-2020.
Calinski DM, et al. A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics. Psychopharmacology. 2018.
Baselt RC. Disposition of Toxic Drugs and Chemicals in Man. 9th ed. Biomedical Publications; 2011:276-277.

DISCLAIMER: This document is intended for clinical reference and educational purposes only. It does not constitute medical, legal, or professional advice and should not replace independent clinical or programmatic judgment. Content reflects published data available at time of preparation. ToxiPharm LLC makes no warranties regarding completeness or applicability in all settings. | © 2026 ToxiPharm LLC | toxipharm.org